[Evaluation of MYCN amplification in Iranian patients with neuroblastoma by conventional and real time PCR]

Behzad, Poopak; Mohammad, Arzanian; Parvaneh, Vosough; Atoosa, Gharib; Amir, Hamidieh; Mohammad, Ehsani; Masood, Parsania; Abolfazl, Yousefian; Mohammad, Jahangirpour; Kobra, Farahani

Behzad, Poopak; Mohammad, Arzanian; Parvaneh, Vosough; Atoosa, Gharib; Amir, Hamidieh; Mohammad, Ehsani; Masood, Parsania; Abolfazl, Yousefian; Mohammad, Jahangirpour; Kobra, Farahani.

Medical Sciences Journal of Islamic Azad University. 2011; 21 (3): 188-195

in Persian | IMEMR | ID: emr-194714

ABSTRACT

ABSTRACT

Background:

There is an international consensus that evaluation of MYCNamplification should be done in all cases of newly diagnosed neuroblastoma. MYCN is the most important prognostic factor for neuroblastoma and determines treatment strategy

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Language: Persian Journal: Med. Sci. J. Islam. Azad Univ. Year: 2011

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Language: Persian Journal: Med. Sci. J. Islam. Azad Univ. Year: 2011